申请人:JIANGSU KANION PHARMACEUTICAL CO. LTD
公开号:US20170066732A1
公开(公告)日:2017-03-09
Disclosed is a novel anti-enterovirus 71 (EV71) 1,2,5-thiadiazolidine-1,1-dioxide derivative or a pharmaceutically acceptable salt thereof; and specifically, a compound represented by formula (II) or a pharmaceutically acceptable salt thereof.
揭示了一种新型抗肠道病毒71(EV71)1,2,5-噻二唑啉-1,1-二氧化物衍生物或其药用盐;具体而言,是由式(II)表示的化合物或其药用盐。